Daiwa Securities Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-266
| Closed | -$5K | – | 1472 |
|
|
2021
Q3 | $5K | Buy |
266
+125
| +89% | +$2.35K | ﹤0.01% | 1181 |
|
|
2021
Q2 | $5K | Hold |
141
| – | – | ﹤0.01% | 1076 |
|
|
2021
Q1 | $4K | Hold |
141
| – | – | ﹤0.01% | 1095 |
|
|
2020
Q4 | $3K | Sell |
141
-281
| -67% | -$5.98K | ﹤0.01% | 1100 |
|
|
2020
Q3 | $8K | Buy |
422
+36
| +9% | +$682 | ﹤0.01% | 1053 |
|
|
2020
Q2 | $7K | Hold |
386
| – | – | ﹤0.01% | 1076 |
|
|
2020
Q1 | $7K | Hold |
386
| – | – | ﹤0.01% | 1074 |
|
|
2019
Q4 | $9K | Sell |
386
-50
| -11% | -$1.17K | ﹤0.01% | 1067 |
|
|
2019
Q3 | $6K | Buy |
436
+37
| +9% | +$509 | ﹤0.01% | 1059 |
|
|
2019
Q2 | $6K | Hold |
399
| – | – | ﹤0.01% | 1074 |
|
|
2019
Q1 | $6K | Sell |
399
-201
| -34% | -$3.02K | ﹤0.01% | 1063 |
|
|
2018
Q4 | $6K | Buy |
+600
| New | +$6K | ﹤0.01% | 1038 |
|